Acetylsalicylic Acid as Secondary Prevention in Colorectal Cancer
This study is testing if a daily low-dose aspirin can help prevent colorectal cancer from returning after liver surgery. Researchers want to see if this common, affordable medication can help patients live cancer-free for longer.
This study is no longer enrolling. It included adults whose colorectal cancer had spread to the liver and who had surgery or local treatment to remove it with the aim of cure, and who were generally able to care for themselves. People who already took aspirin, blood thinners, certain anti-inflammatory drugs, or who had bleeding disorders could not take part.
Participants will be randomly assigned to take either a low-dose aspirin or an inactive pill (placebo) once a day for up to three years. You will also continue to receive your standard medical check-ups and follow your regular doctor care plan.
The study took place at 14 hospitals in Norway, Sweden, and Denmark, led by Oslo University Hospital. It is not recruiting new participants.
- 1Tests if daily low-dose aspirin helps prevent cancer from returning after liver surgery
- 2Involves taking either aspirin or a placebo pill for up to three years
- 3Took place at 14 hospitals in Norway, Sweden, and Denmark
Related video
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.